AU2001296215A1 - Efficient method of synthesizing combretastatin a-4 prodrugs - Google Patents
Efficient method of synthesizing combretastatin a-4 prodrugsInfo
- Publication number
- AU2001296215A1 AU2001296215A1 AU2001296215A AU9621501A AU2001296215A1 AU 2001296215 A1 AU2001296215 A1 AU 2001296215A1 AU 2001296215 A AU2001296215 A AU 2001296215A AU 9621501 A AU9621501 A AU 9621501A AU 2001296215 A1 AU2001296215 A1 AU 2001296215A1
- Authority
- AU
- Australia
- Prior art keywords
- prodrugs
- efficient method
- combretastatin
- synthesizing
- synthesizing combretastatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21876600P | 2000-07-17 | 2000-07-17 | |
US60/218,766 | 2000-07-17 | ||
PCT/US2001/022403 WO2002006279A1 (en) | 2000-07-17 | 2001-07-17 | Efficient method of synthesizing combretastatin a-4 prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296215A1 true AU2001296215A1 (en) | 2002-01-30 |
Family
ID=22816425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296215A Abandoned AU2001296215A1 (en) | 2000-07-17 | 2001-07-17 | Efficient method of synthesizing combretastatin a-4 prodrugs |
Country Status (3)
Country | Link |
---|---|
US (1) | US6743937B2 (en) |
AU (1) | AU2001296215A1 (en) |
WO (1) | WO2002006279A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7576084B2 (en) * | 2001-10-12 | 2009-08-18 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
JP2005514450A (en) | 2001-12-21 | 2005-05-19 | アリゾナ ボード オブ リーゼンツ | Synthesis of combretastatin A-2 prodrug |
US7705188B2 (en) * | 2002-04-10 | 2010-04-27 | Arizona Board of Regents, a body corporate of the State of Arizona, Acting for and on Behalf of the Arizona State University | Structural modification of resveratrol: sodium resverastatin phosphate |
GB0306907D0 (en) * | 2003-03-26 | 2003-04-30 | Angiogene Pharm Ltd | Boireductively-activated prodrugs |
CN100343216C (en) * | 2004-05-25 | 2007-10-17 | 浙江大德药业集团有限公司 | Synthesis of Combretastatin A-4 supported by polymer |
CN101023119B (en) * | 2004-09-22 | 2010-05-05 | 日本化药株式会社 | Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
CN1312161C (en) * | 2005-04-30 | 2007-04-25 | 中国科学院广州化学研究所 | 3-hydroxy-4,3',4',5'-tetromethoxy bibenzyl phosphate and its composition, prepn and application |
FR2895735B1 (en) | 2005-12-30 | 2008-04-18 | Ecopack France | IMPROVED POCKET VALVE |
KR20080106254A (en) | 2006-03-28 | 2008-12-04 | 니폰 가야꾸 가부시끼가이샤 | Polymer conjugate of taxane |
WO2007135910A1 (en) | 2006-05-18 | 2007-11-29 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of podophyllotoxin |
AU2007274402A1 (en) | 2006-07-19 | 2008-01-24 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of combretastatin |
CA2664852A1 (en) * | 2006-10-03 | 2008-04-10 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of resorcinol derivatives |
WO2008056596A1 (en) | 2006-11-06 | 2008-05-15 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
EP2090607B1 (en) | 2006-11-08 | 2015-05-20 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
WO2009041570A1 (en) | 2007-09-28 | 2009-04-02 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of steroid |
PL2219451T3 (en) | 2007-11-21 | 2015-04-30 | Oxigene Inc | Method for treating hematopoietic neoplasms |
CN101977631A (en) | 2008-03-18 | 2011-02-16 | 日本化药株式会社 | Polymer conjugate of physiologically active substance |
WO2009136572A1 (en) | 2008-05-08 | 2009-11-12 | 日本化薬株式会社 | Polymer conjugate of folic acid or folic acid derivative |
US8808749B2 (en) | 2009-05-15 | 2014-08-19 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of bioactive substance having hydroxy group |
CA2766178A1 (en) * | 2009-07-02 | 2011-01-06 | Oxigene, Inc. | Combretastatins for prevention of posterior capsule opacification |
WO2011036674A1 (en) * | 2009-09-24 | 2011-03-31 | Inogent Laboratories Private Limited | A new process for the preparation of olmesartan medoxomil |
FR2953518B1 (en) * | 2009-12-03 | 2012-01-20 | Sanofi Aventis | PROCESS FOR PREPARING A COMBRETASTATIN DERIVATIVE |
EP2641605B1 (en) | 2010-11-17 | 2018-03-07 | Nippon Kayaku Kabushiki Kaisha | Polymer derivative of cytidine metabolism antagonist |
RU2623426C2 (en) | 2011-09-11 | 2017-06-26 | Ниппон Каяку Кабусики Кайся | Method of obtaining a block copolymer |
CN103102254B (en) * | 2013-02-06 | 2015-08-26 | 浙江新赛科药业有限公司 | The synthetic method of a kind of Pterostilene |
CN104892668B (en) * | 2015-05-12 | 2017-03-29 | 上海大学 | Prodrug and preparation method thereof before combretastatin analog water solublity |
WO2017031157A1 (en) | 2015-08-18 | 2017-02-23 | Mateon Therapeutics, Inc. | Use of vdas to enhance immunomodulating therapies against tumors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670193A (en) * | 1986-05-12 | 1987-06-02 | E. R. Squibb & Sons, Inc. | Process for preparing phosphonic acids |
US4996237A (en) | 1987-01-06 | 1991-02-26 | Arizona Board Of Regents | Combretastatin A-4 |
CA1338645C (en) | 1987-01-06 | 1996-10-15 | George R. Pettit | Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins" |
GB9106177D0 (en) | 1991-03-22 | 1991-05-08 | Aston Molecules Ltd | Substituted diphenylethylenes and analogues or derivatives thereof |
US5561122A (en) | 1994-12-22 | 1996-10-01 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Combretastatin A-4 prodrug |
DE69942645D1 (en) | 1998-01-09 | 2010-09-16 | Body Corporate Of The State Of | Synthese von combretastatin a-4 prodrugs |
-
2001
- 2001-07-17 AU AU2001296215A patent/AU2001296215A1/en not_active Abandoned
- 2001-07-17 US US09/908,321 patent/US6743937B2/en not_active Expired - Lifetime
- 2001-07-17 WO PCT/US2001/022403 patent/WO2002006279A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002006279A1 (en) | 2002-01-24 |
WO2002006279A9 (en) | 2003-04-03 |
WO2002006279A3 (en) | 2002-04-18 |
US6743937B2 (en) | 2004-06-01 |
US20020119951A1 (en) | 2002-08-29 |
WO2002006279A8 (en) | 2002-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001296215A1 (en) | Efficient method of synthesizing combretastatin a-4 prodrugs | |
EP1318798A4 (en) | Water-soluble prodrugs of propofol for treatment of migraine | |
AU2001284514A1 (en) | Process for producing ester | |
AU2001229676A1 (en) | Production of monocycloalkyl aromatic compounds | |
AU2002239403A1 (en) | Tissue specific prodrugs | |
AU2001282147A1 (en) | Enzymatic synthesis of antioxidant hydroxytyrosol | |
AU2001244470A1 (en) | Assembly process | |
AU2001273598A1 (en) | Carbonate-based photoresist stripping compositions | |
AU7964600A (en) | Production method of radiators | |
AU2000254942A1 (en) | 7-phenyl-substituted tetracycline compounds | |
AU2001291313A1 (en) | Process for making 3-amino-2-chloro-4-methylpyridine | |
AU2001296527A1 (en) | Resist stripping process | |
AU2002239405A1 (en) | Tetrapartate prodrugs | |
PL373510A1 (en) | Methods of synthesizing phenol-containing compounds | |
AU2001295934A2 (en) | Process for producing substituted aniline compound | |
AU2001295934A1 (en) | Process for producing substituted aniline compound | |
AU3228301A (en) | Process for producing fumaric ester | |
AU2001265935A1 (en) | Production of biohydrolysates | |
AU2410101A (en) | Production method of multi-gauge strips | |
HUP0303102A3 (en) | Process for producing substituted aniline compound | |
AU2001281827A1 (en) | Method for producing 5-aminosalicyclic acid | |
AU2001227697A1 (en) | Method for purification of acetone | |
AU2002218440A1 (en) | New process | |
EP1215193A3 (en) | Production of 2-hydrocarbyl-2-adamantyl acrylate compounds | |
AUPP132198A0 (en) | Improved production of reticuline |